Intech Biopharm Corporation (TPEX:6461)
19.80
-0.95 (-4.58%)
Mar 9, 2026, 1:30 PM CST
Intech Biopharm Market Cap
Intech Biopharm has a market cap or net worth of 3.23 billion as of March 9, 2026. Its market cap has decreased by -13.39% in one year.
Market Cap
3.23B
Enterprise Value
4.35B
Revenue
113.85M
Ranking
n/a
PE Ratio
n/a
Stock Price
19.80
Market Cap Chart
Since July 15, 2014, Intech Biopharm's market cap has decreased from 4.00B to 3.23B, a decrease of -19.45%. That is a compound annual growth rate of -1.84%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shine-On BioMedical | 3.43B |
| BRIM Biotechnology | 3.44B |
| Sagittarius Life Science | 3.51B |
| SYN-TECH Chem. & Pharm. | 3.19B |
| Syngen Biotech | 3.10B |
| 3D Global Biotech | 3.05B |
| ACRO Biomedical | 3.75B |
| Apex Biotechnology | 2.94B |